This year, the domestic health supplement market is expected to see a slight decline, but pharmaceutical companies are actively working to expand their health supplement businesses. With increasing pressure on profitability in the pharmaceutical sector due to drug price reductions, companies are seeking breakthroughs in the relatively less regulated health supplement market.
According to the '2026 Health Supplement Market Status and Consumer Survey' published by the Korea Health Supplement Association on November 18, the domestic health supplement market size is estimated to be 6.13 trillion won (KRW), a 0.7% decrease from last year's 6.17 trillion won (KRW). Although the market size has decreased, the consumer base has actually expanded. The purchase experience rate, which indicates the percentage of households that purchased health supplements in the past year, rose from 81.6% last year to 82.7% this year, marking the highest level in three years.
The number of purchasing households increased from 18.01 million to 18.32 million. However, the average annual purchase amount per household decreased slightly to about 334,000 won (KRW) from 342,683 won (KRW) last year. Industry analysts attribute this decline in average spending to a shift in consumer behavior from families consuming the same products together to individuals selecting products based on age, health status, and needs.
Low-cost distribution channels are also expanding the market. Daiso began selling over 30 types of health supplements from Daewoong Pharmaceutical, Il Yang Pharmaceutical, and Chong Kun Dang Health at more than 200 stores nationwide last February. As of the end of September this year, the number of partner companies has increased to 25, with 220 products available. Products that previously cost 20,000 to 30,000 won (KRW) are now offered at a uniform price of 3,000 to 5,000 won (KRW), attracting demand from younger consumers and single-person households. According to Daiso, health supplement sales in the third quarter of this year (July to September) increased by about 80% compared to the same period last year.
Pharmaceutical companies are positioning their health supplement businesses as a key area for revenue diversification. Unlike pharmaceuticals, where pricing and marketing are strictly regulated, health supplements allow for relatively free pricing and promotions. The ability to leverage technology and brand trust developed through pharmaceutical research and development (R&D) is also an advantage.
Despite a stagnant market, it appears that health supplement sales for pharmaceutical companies are increasing. Dongkook Pharmaceutical reported a 30% increase in health supplement sales in the third quarter of this year compared to the same period last year. Earlier this year, Dongkook Pharmaceutical launched the 'Dongkook Health' project, focusing on essential nutrients such as probiotics and omega-3 vitamin C, expanding its product range.
New product launches are also occurring monthly. Last month, Dong-A Pharmaceutical introduced 'Orthomol Vitamin C Depot,' a sustained-release vitamin C product, while Hanmi Pharmaceutical launched three types of weight management health supplements called 'Epislim.' This month, Yuhan Corporation released a joint health supplement, 'Yuhan Chondroitin 1200 Gold Stick,' and Chong Kun Dang Health launched a new ginseng brand, 'Hong Sam Dang Dang.'
As the management environment of the pharmaceutical industry worsens due to drug price reductions, industry insiders expect this diversification of business will become more widespread. For small and medium-sized pharmaceutical companies that find it difficult to invest large sums in new drug development, the importance of entering the non-pharmaceutical business, which has lower barriers to entry, is likely to increase.
However, as the health supplement market itself enters a stagnation phase, competition among companies is expected to intensify. An industry insider pointed out, "Without product differentiation, increasing marketing costs could actually worsen profitability."
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.